Oracle Corp: Form 10-Q for the period ended Aug 31, 2023
Filed with the SEC on Sep 12, 2023 and accepted by EDGAR at Sep 12, 2023, 16:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-06-01 to 2023-08-31 | $12.45bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2023-06-01 to 2023-08-31 | $2.22bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-06-01 to 2023-08-31 | $3.30bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-06-01 to 2023-08-31 | $872.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-06-01 to 2023-08-31 | −$45.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-06-01 to 2023-08-31 | $2.42bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-06-01 to 2023-08-31 | $0.86 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-06-01 to 2023-08-31 | $0.89 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-06-01 to 2023-08-31 | 2,823,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-06-01 to 2023-08-31 | $6.97bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-06-01 to 2023-08-31 | $1.31bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-06-01 to 2023-08-31 | $1.09bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2023-06-01 to 2023-08-31 | $150.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-08-31 | $11.61bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-08-31 | $22.17bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-08-31 | $136.66bn | us-gaap:Assets |
| Current liabilities | At period end2023-08-31 | $25.36bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2023-08-31 | $2.37bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-09-07 | 2,739,821,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-047713. Last ingested by Listed: Oct 27, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.